| Ident. | Authors (with country if any) | Title |
|---|
| 000013 (2013) |
Micha Levi [États-Unis] ; Susan Grange [États-Unis] ; Nicolas Frey [Suisse] | Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis |
| 000014 (2012) |
Seiji Ohtori [Japon] ; Masayuki Miyagi [Japon] ; Yawara Eguchi [Japon] ; Gen Inoue [Japon] ; Sumihisa Orita [Japon] ; Nobuyasu Ochiai [Japon] ; Shunji Kishida [Japon] ; Kazuki Kuniyoshi [Japon] ; Junichi Nakamura [Japon] ; Yasuchika Aoki [Japon] ; Tetsuhiro Ishikawa [Japon] ; Gen Arai [Japon] ; Hiroto Kamoda [Japon] ; Miyako Suzuki [Japon] ; Masashi Takaso [Japon] ; Takeo Furuya [Japon] ; Gou Kubota [Japon] ; Yoshihiro Sakuma [Japon] ; Yasuhiro Oikawa [Japon] ; Tomoaki Toyone [Japon] ; Kazuhisa Takahashi [Japon] | Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica |
| 000069 (2016) |
Nozomu Yanaihara [Japon] ; Yukihiro Hirata [Japon] ; Noriko Yamaguchi [Japon] ; Yukiko Noguchi [Japon] ; Misato Saito [Japon] ; Chie Nagata [Japon] ; Satoshi Takakura [Japon] ; Kyosuke Yamada [Japon] ; Aikou Okamoto [Japon] | Antitumor effects of interleukin‐6 (IL‐6)/interleukin‐6 receptor (IL‐6R) signaling pathway inhibition in clear cell carcinoma of the ovary |
| 000105 (2012) |
M. Gallego-Galisteo ; A. Villa-Rubio ; E. Alegre-Del Rey [Espagne] ; E. Márquez-Fernández ; J. J. Ramos-Báez | Indirect comparison of biological treatments in refractory rheumatoid arthritis |
| 000147 (2010) |
Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Hiromi Hagiwara [Japon] ; Akihiro Narita [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Tatsuya Atsumi [Japon] ; Hiroki Shirato [Japon] ; Satoshi Terae [Japon] | Monitoring anti-interleukin 6 receptor antibody treatment for rheumatoid arthritis by quantitative magnetic resonance imaging of the hand and power Doppler ultrasonography of the finger |
| 000169 (2015) |
Yanli Zhuang [États-Unis] ; Dick E. De Vries [Pays-Bas] ; Zhenhua Xu [États-Unis] ; Stanley J. Marciniak Jr. [États-Unis] ; Dion Chen [États-Unis] ; Francisco Leon [États-Unis] ; Hugh M. Davis [États-Unis] ; Honghui Zhou [États-Unis] | Evaluation of disease‐mediated therapeutic protein–drug interactions between an anti–interleukin‐6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach |
| 000250 (2009) |
Luca Semerano [France] ; Marie-Christophe Boissier [France] | Les anticorps monoclonaux dans les maladies immunes inflammatoires chroniques |
| 000258 (2010) |
Scott M. Steward-Tharp [États-Unis, Royaume-Uni] ; Yun-Jeong Song [États-Unis] ; Richard M. Siegel [États-Unis] ; John J. O'Shea [États-Unis] | New insights into T cell biology and T cell‐directed therapy for autoimmunity, inflammation, and immunosuppression |
| 000282 (2010) |
Gert Hein [Allemagne] ; Thorsten Eidner [Allemagne] ; Peter Oelzner [Allemagne] ; Michael Rose [Allemagne] ; Alexander Wilke [Allemagne] ; Gunter Wolf [Allemagne] ; Sybille Franke [Allemagne] | Influence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot study |
| 000294 (2013) |
Shunsei Hirohata [Japon] ; Tetsuya Tomita [Japon] ; Hideki Yoshikawa [Japon] ; Masahisa Kyogoku [Japon] | TNF inhibitors induce discoid fibrosis in the sublining layers of the synovium with degeneration of synoviocytes in rheumatoid arthritis |
| 000298 (2012) |
Yin Liu [États-Unis] ; Yuval Ramot [Israël] ; Antonio Torrelo [Espagne] ; Amy S. Paller [États-Unis] ; Nuo Si [République populaire de Chine] ; Sofia Babay [Israël] ; Peter W. Kim [États-Unis] ; Afzal Sheikh [États-Unis] ; Chyi-Chia Richard Lee [États-Unis] ; Yongqing Chen [États-Unis] ; Angel Vera [Espagne] ; Xue Zhang [République populaire de Chine] ; Raphaela Goldbach-Mansky [États-Unis, Israël] ; Abraham Zlotogorski [Israël] | Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity |
| 000314 (2010) |
Ukihide Tateishi [Japon] ; Tomoyuki Imagawa [Japon] ; Noriko Kanezawa [Japon] ; Tetsuhiko Okabe [Japon] ; Kazuya Shizukuishi [Japon] ; Tomio Inoue [Japon] ; Shumpei Yokota [Japon] | PET assessment of disease activity in children with juvenile idiopathic arthritis |
| 000326 (2015) |
Takeshi Sainoh [Japon] ; Sumihisa Orita [Japon] ; Masayuki Miyagi [Japon] ; Yoshihiro Sakuma [Japon] ; Kazuyo Yamauchi [Japon] ; Miyako Suzuki [Japon] ; Go Kubota [Japon] ; Yasuhiro Oikawa [Japon] ; Kazuhide Inage [Japon] ; Jun Sato [Japon] ; Kazuki Fujimoto [Japon] ; Yasuhiro Shiga [Japon] ; Gen Inoue [Japon] ; Yasuchika Aoki [Japon] ; Kazuhisa Takahashi [Japon] ; Seiji Ohtori [Japon] | Interleukin‐6 and interleukin‐6 receptor expression, localization, and involvement in pain‐sensing neuron activation in a mouse intervertebral disc injury model |
| 000337 (2011) |
Sylvie Fabre [France] | Approches pharmacologiques en immuno-rhumatologie |
| 000461 (2011) |
Alberto Migliore [Italie, Espagne] ; Emanuele Bizzi [Italie] ; Serena Broccoli [Italie] ; Bruno Laganà [Italie] | Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator |
| 000479 (2013) |
M. Lisbona ; J. Maymo ; A. Pàmies ; J. Ares [Espagne] ; A. Solano [Espagne] ; M. Almirall ; S. Sanchez ; J. Carbonell | AB0542 Early reduction in synovitis and bone EDEMA evaluated by MRI in tocilizumab-treated RA patients with inadequate response to anti-TNF |
| 000504 (2013) |
M. A. Cimmino ; P. Sarzi-Puttini ; S. Bombardieri [Italie] ; A. Iagnocco [Italie] ; L. Sinigaglia ; F. Debenedetti [Italie] | SAT0114 Effects Of Tocilizumab (TCZ) in Combination with Non-Biologic Dmards in the Inhibition of Progression of Synovitis, Bone Marrow Edema and Erosions Evaluated by Extremity-Dedicated Magnetic Resonance Imaging (MRI) In Rheumatoid Arthritis (RA) |
| 000511 (2011) |
Stefan Kleinert [Allemagne] ; Hans-Peter Tony [Allemagne] ; Andreas Krause [Allemagne] ; Martin Feuchtenberger [Allemagne] ; Siegfried Wassenberg [Allemagne] ; Constanze Richter [Allemagne] ; Ekkehard Röther [Allemagne] ; Wolfgang Spieler [Allemagne] ; Holger Gnann [Allemagne] ; Bianca M. Wittig [Allemagne] | Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study |
| 000545 (2011) |
H. Tadaki [Japon] ; H. Saitsu [Japon] ; H. Kanegane [Japon] ; N. Miyake [Japon] ; T. Imagawa [Japon] ; M. Kikuchi [Japon] ; R. Hara [Japon] ; U. Kaneko [Japon] ; T. Kishi [Japon] ; T. Miyamae [Japon] ; A. Nishimura [Japon] ; H. Doi [Japon] ; Y. Tsurusaki [Japon] ; H. Sakai [Japon] ; S. Yokota [Japon] ; N. Matsumoto [Japon] | Exonic deletion of CASP10 in a patient presenting with systemic juvenile idiopathic arthritis, but not with autoimmune lymphoproliferative syndrome type IIa |
| 000748 (2012) |
Ariel C. Bulua [États-Unis] ; Douglas B. Mogul [États-Unis] ; Ivona Aksentijevich [États-Unis] ; Harjot Singh [États-Unis] ; David Y. He [États-Unis] ; Larry R. Muenz [États-Unis] ; Michael M. Ward [États-Unis] ; Cheryl H. Yarboro [États-Unis] ; Daniel L. Kastner [États-Unis] ; Richard M. Siegel [États-Unis] ; Keith M. Hull [États-Unis] | Efficacy of etanercept in the tumor necrosis factor receptor–associated periodic syndrome: A prospective, open‐label, dose‐escalation study |
| 000880 (2012) |
Metin Isik [Turquie] ; Burcin Halacli [Turquie] ; Özgür Atmaca [Turquie] ; Sezgin Etgül [Turquie] ; Smail Do An [Turquie] ; Levent K L Nç [Turquie] ; Meral Çalgüneri [Turquie] | Triple DMARD combination for rheumatoid arthritis resistant to methotrexate and steroid combination: a single-center experience |
